Expression patterns of CD168 correlate with the stage and grade of squamous cell carcinoma of head and neck

  • Authors:
    • Korinna Jöhrens
    • Ioannis Anagnostopoulos
    • Steffen Dommerich
    • Jan Dirk Raguse
    • Agnieszka J. Szczepek
    • Frederick Klauschen
    • Katharina Stölzel
  • View Affiliations

  • Published online on: February 13, 2017     https://doi.org/10.3892/mco.2017.1165
  • Pages: 597-602
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The receptor for hyaluronan-mediated motility CD168 is associated with the processes of oncogenesis and metastasis. The objective of the present study was to determine the possible association between the expression and distribution of CD168 and the tumor stage of head-and-neck squamous cell carcinoma (SCC). Formalin-fixed and paraffin-embedded tumor samples obtained from 100 patients during primary resection of SCC from the oral cavity, oropharynx, hypopharynx or larynx were included in the present study. The patients were divided into two risk groups: Low risk, representing the early stage of completely resected SCCs with good-to-moderate differentiation, and the high-risk group, representing the advanced stage SCCs with positive resection margins, vascular invasion or locoregional metastasis. All specimens were stained with a monoclonal antibody against CD168. Percentage and staining intensity of CD168-positive cells were scored, and their spatial distribution within the tumor nests was noted. The results obtained were correlated with the tumor stage. The quantification of CD168 expression revealed significant differences between the two risk groups (t-test, P=0.002), with higher scores in tumors resected from the high-risk SSC group compared with those from the low-risk group. In addition, in the high-risk group, the CD168-positive cells were present predominantly in the periphery (70.4%) of tumor nests, whereas in the low-risk group, only 56.6% were located there; however, this trend did not reach the level of statistical significance. Taken together, the results from the present study suggested that CD168 expression patterns could potentially be used as a predictor of tumor aggressiveness, and therefore they may be a prognostic factor in head-and-neck SCC.
View Figures
View References

Related Articles

Journal Cover

April 2017
Volume 6 Issue 4

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Jöhrens, K., Anagnostopoulos, I., Dommerich, S., Raguse, J.D., Szczepek, A.J., Klauschen, F., & Stölzel, K. (2017). Expression patterns of CD168 correlate with the stage and grade of squamous cell carcinoma of head and neck. Molecular and Clinical Oncology, 6, 597-602. https://doi.org/10.3892/mco.2017.1165
MLA
Jöhrens, K., Anagnostopoulos, I., Dommerich, S., Raguse, J. D., Szczepek, A. J., Klauschen, F., Stölzel, K."Expression patterns of CD168 correlate with the stage and grade of squamous cell carcinoma of head and neck". Molecular and Clinical Oncology 6.4 (2017): 597-602.
Chicago
Jöhrens, K., Anagnostopoulos, I., Dommerich, S., Raguse, J. D., Szczepek, A. J., Klauschen, F., Stölzel, K."Expression patterns of CD168 correlate with the stage and grade of squamous cell carcinoma of head and neck". Molecular and Clinical Oncology 6, no. 4 (2017): 597-602. https://doi.org/10.3892/mco.2017.1165